Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria
This study has been completed.
Study NCT00351273 Information provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
First Received: July 10, 2006 Last Updated: January 29, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Arthritis, Reactive
Reiter Disease
Additional conditions recognized in this trial
Arthritis
More general conditions related to this trial
Arthritis, Infectious
Bone Diseases
Infection
Joint Diseases
Musculoskeletal Diseases
Spinal Diseases
Spondylarthritis
Spondylarthropathies
Interventions listed in this trial
Doxycycline and Rifampin
Azithromycin and Rifampin
Placebo
Additional drug interventions recognized in this trial
Anti-Bacterial Agents
Azithromycin
Doxycycline
Rifampin
More general drug interventions related to this trial
Anti-Infective Agents
Antibiotics, Antitubercular
Antimalarials
Antiparasitic Agents
Antiprotozoal Agents
Antitubercular Agents
Enzyme Inhibitors
Leprostatic Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Back to top of Main Content
